the invention relates to crystalline forms of - 5 -- benzylidene ]- 2 -- propylimino )- 3 - o - tolyl - thiazolidin - 4 - one , processes for the preparation thereof , pharmaceutical compositions containing said crystalline forms , and their use as compounds improving vascular function and as immunomodulating agents , either alone or in combination with other active compounds or therapies .